Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
Global Cancer Immunotherapy Market Analysis & Forecast to 2025: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors
US$ 4,900.00
Within the cancer therapeutics space, which today is worth over $160 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that hav...
November 2020
450 pages
Global PCR & Real-time PCR Molecular Diagnostics Market Size study, by Technology (Traditional PCR, Real-time PCR, Digital PCR), By Product (Instruments, Reagents and Consumables), By Application (Infectious Diseases Testing and Oncology Testing), By End-Users (Hospitals, Diagnostic Laboratories, Academic & Research Centers and Others) and Regional Forecasts 2020-2027
US$ 4,950.00
Global PCR & Real-time PCR Molecular Diagnostics Market is valued approximately USD 4.10 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 4.00% over the forecast peri...
October 2020
200 pages
Hemato Oncology Testing Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Services), By Cancer Type (Leukemia, Lymphoma, MPNs), By Technology, By End-use, By Region, And Segment Forecasts, 2020 - 2027
US$ 5,950.00
This report can be delivered to the clients within 72 Business Hours Hemato Oncology Testing Market Growth & Trends The global hemato oncology testing market size is expected to reach USD 7.2 billio...
October 2020
142 pages
Global Breast Cancer Therapeutics Market Size study, By Product (Hormone Drugs, Chemotherapy Drugs, Targeted Drug Therapy), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, Clinics, e-commerce, Retail Pharmacies), and Regional Forecasts 2020-2027
US$ 3,950.00
Global Breast Cancer Therapeutics Market is valued approximately at USD 19.57 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 10.16% over the forecast period 2020-20...
October 2020
200 pages
